Value Sense
ENFN
Enfusion, Inc. (ENFN)
Last Price$11.10.1%
Market Cap$1,440.8M
P/OCF LTM
44.0x
5Y avg
(280.3x)
Software - Application industry median
14.7x
Stock quality & Intrinsic value
6/10
0.3% undervalued
ENFN
is 28.0% undervalued
learn more -->
50+
undervalued stocks
Start beating the S&P 500

Enfusion, Inc. P/OCF LTM

Annual
Quarterly
Daily
Crunching data... Almost there!
Dec'21Dec'22Dec'23Dec'24
P/OCF LTM
(453.3x)
1,424.8x
44.4x
44.0x
ENFN
Key metrics and insights to make informed decisions.
View full analysis
Overvalued or undervalued?
Check the intrinsic value for ENFN and see if it's the right time to invest.
Dive in

Enfusion, Inc. (ENFN) P/OCF LTM comparison analysis

General

LTM P/OCF LTM

OTHER METRICS

Company name

Revenue growth

EPS growth

Net Income margin

Enfusion, Inc. logo
Enfusion, Inc.ENFN
41.5x
15.5%
(81.2%)
1.4%
Median Peer Set
33.8x
14.9%
12.8%
17.3%
Shopify Inc. logo
Shopify Inc.SHOP
74.4x
25.8%
1,470.0%
22.7%
SAP SE logo
SAP SESAP
53.3x
9.6%
(49.0%)
9.1%
Cadence Design Systems, Inc. logo
Cadence Design Systems, Inc.CDNS
50.4x
13.5%
0.8%
22.7%
AppLovin Corporation logo
AppLovin CorporationAPP
40.6x
43.4%
363.4%
33.5%
ServiceNow, Inc. logo
ServiceNow, Inc.NOW
39.4x
22.4%
(18.4%)
13.0%
Intuit Inc. logo
Intuit Inc.INTU
28.2x
13.3%
24.8%
18.2%
Workday, Inc. logo
Workday, Inc.WDAY
26.3x
16.4%
(62.5%)
6.2%
Uber Technologies, Inc. logo
Uber Technologies, Inc.UBER
21.0x
18.0%
423.3%
22.4%
Salesforce, Inc. logo
Salesforce, Inc.CRM
20.4x
8.7%
51.5%
16.4%
MicroStrategy Incorporated logo
MicroStrategy IncorporatedMSTR
(1,025.7x)
(6.6%)
N/A
(251.7%)

ENFN key stats

USD
Millions
Billions
Annual
Quarterly
Trailing
Key stats
Income statement
Balance sheet
Cash Flow Statement
Valuation
Ratios
Per share
Per employee
Dividends & Yields
Dec'19Dec'20Dec'21Dec'22Dec'23Dec'24
Revenue
% growth
59.0
0.0%
79.6
34.8%
111.7
40.4%
150.3
34.6%
174.5
16.1%
201.6
15.5%
Cost of Goods Sold (COGS)17.021.431.847.157.664.9
Gross Profit
% margin
42.1
71.3%
58.2
73.2%
79.9
71.5%
103.2
68.7%
116.9
67.0%
136.7
67.8%
Operating Expenses28.252.1355.7115.2104.9130.6
Research & Development Expenses (R&D)4.16.3153.417.219.926.7
Selling, General & Administrative Expenses (SG&A)24.145.8202.398.185.1103.9
Operating Income
% margin
13.9
23.5%
6.1
7.6%
(275.9)
(247.0%)
(12.0)
(8.0%)
11.9
6.8%
6.2
3.1%
Interest Income0.71.74.60.40.01.7
Interest Expense0.71.74.60.40.00.0
Pre-tax Income13.14.5(281.7)(12.2)11.57.4
Income Tax
% effective tax rate
0.5
3.7%
0.4
9.6%
0.6
(0.2%)
1.1
(8.8%)
2.2
19.4%
4.6
61.8%
Net Income
% margin
12.7
21.4%
4.1
5.1%
(282.2)
(252.7%)
(13.3)
(8.8%)
6.0
3.5%
2.8
1.4%
EPS0.110.04(4.30)(0.16)0.100.02
Diluted EPS0.110.04(4.30)(0.16)0.070.01
EBITDA
% margin
15.0
25.5%
8.4
10.5%
(271.9)
(243.4%)
(5.6)
(3.7%)
21.9
12.6%
6.2
3.1%

Discover more Stock Ideas

Undervalued stocks right now

Undervalued stocks right now

Discover the top 20 best undervalued stocks to buy for Mar 2025, listed on the Nasdaq or NYSE.

3M Return 32.1%
S&P Outperformance 19.1%
Next 3M Predicted Return 20.3%
Undervalued growth stocks

Undervalued growth stocks

Discover the top 20 best undervalued large-cap growth stocks to buy for Mar 2025, listed on the Nasdaq or NYSE.

3M Return 35.3%
S&P Outperformance 22.3%
Next 3M Predicted Return 26.8%
Undervalued dividend stocks

Undervalued dividend stocks

Discover the top 20 best undervalued high-yield dividend stock that offers both growth potential and attractive dividend returns for Mar 2025.

3M Return 28.4%
S&P Outperformance 15.4%
Next 3M Predicted Return 16.9%
More ideas -->

FAQ

1) What is Enfusion, Inc.'s P/OCF LTM?

As of today, Microsoft Corp's last 12-month P/OCF LTM is 44.0x, based on the financial report for Dec 30, 2024 (Q4’2024). The average annual P/OCF LTM for Enfusion, Inc. have been (242.9x) over the past three years, and (182.2x) over the past five years.

2) Is Enfusion, Inc.'s P/OCF LTM Good?

As of today, Enfusion, Inc.'s P/OCF LTM is 44.0x, which is higher than industry median of 14.7x. It indicates that Enfusion, Inc.'s P/OCF LTM is Bad.

3) How does Enfusion, Inc.'s P/OCF LTM compare to its peers?

As of today, Enfusion, Inc.'s P/OCF LTM is 44.0x, which is higher than peer median of 33.8x. The list of peers includes SHOP, SAP, CDNS, APP, NOW, INTU, WDAY, UBER, CRM, MSTR.